HomeKTRA • NASDAQ
add
Kintara Therapeutics Inc
Previous close
$0.21
Day range
$0.19 - $0.21
Year range
$0.081 - $4.59
Market cap
10.96M USD
Avg Volume
3.81M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 2.08M | -36.86% |
Net income | -2.01M | 38.39% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -2.08M | 36.81% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 6.55M | 26.03% |
Total assets | 7.45M | 10.47% |
Total liabilities | 1.52M | -48.41% |
Total equity | 5.92M | — |
Shares outstanding | 55.30M | — |
Price to book | -2.64 | — |
Return on assets | -111.72% | — |
Return on capital | -181.05% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -2.01M | 38.39% |
Cash from operations | -2.30M | -25.89% |
Cash from investing | 0.00 | — |
Cash from financing | 7.99M | 399,750.00% |
Net change in cash | 5.69M | 411.26% |
Free cash flow | -1.46M | 25.01% |
About
Founded
2009
Website
Employees
2